Breaking News

You are here » Indian-Commodity  :  Top News  :  Hinduja Ventures reports marginal fall in Q3 net profit

13-Feb2018

Hinduja Ventures reports marginal fall in Q3 net profit

Hinduja Ventures has reported results for third quarter ended December 31, 2017.

The company has reported a marginal fall of 6.20% in its net profit after tax at Rs 33.76 crore for the quarter under review as compared to Rs 35.99 crore for the same quarter in the previous year. However, total income of the company increased by 22.90% at Rs 64.88 crore for Q3FY18 as compared Rs 52.79 crore for the corresponding quarter previous year. 

Formerly known as Hinduja TMT, Hinduja Ventures is part of the Hinduja Group companies. It is an outsourcing company that provides IT services and BPO/contact center services to customers.


Related News

View all news

Gold futures end higher on Tuesday

Gold futures finished higher on Tuesday, marking biggest single-session percentage rise since November, as investors increased bullion investments amid potential progress on Brexit and trade talks between......

Jeera futures trade lower on NCDEX

Jeera futures traded lower on NCDEX, as speculators reduced exposure on account of reduced export demand in the physical market. Moreover, expectation of higher production due to adequate availability......

Copper futures end higher on weaker dollar

Copper futures ended higher on Tuesday due to a weaker US dollar and hopes that the United States and China would forge a trade deal. A new round of talks between the United States and top metals consumer......

Top News

View all news

Tata Motors signs LTS agreement with its employees

Tata Motors has signed a long-term wage settlement (LTS) agreement with its employees. Under the agreement, workmen will get a wage rise of Rs 9,000 per month along with other incentives based on performance.......

Canara Bank invites bids from merchant bankers to manage its $350-500 million MTN issue: Report

Canara Bank has reportedly invited bids from merchant bankers to manage its $350-500 million issue of senior unsecured/tier-II capital bonds under its medium-term note (MTN) programme. The issue size may......

Alembic Pharma gets USFDA's nod for Acetazolamide Extended-Release Capsules

Alembic Pharmaceuticals (Alembic) has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Acetazolamide Extended-Release Capsules, 500......